por
Keith Loria, Reporter | October 13, 2008
European regulators have given approval to Israel's ITGI Medical to market the company's new pericardium covered coronary stent, called AneuGraft®, a device designed specifically for tortuous arteries.
Company CEO Efri Argaman said that this is the second in a series of heterologous tissue covered stents, designed to set a barrier between the blood vessel wall and its lumen.
"AneuGraft Pericardium Covered Stent is especially suitable for patients with tortuous vessels where other covered stents may not be adequate for use due to limitations resulting from tortuous anatomy," Argaman said.
Ad Statistics
Times Displayed: 9212
Times Visited: 28 Brand-New FDA-cleared Advanced Ultrasound Medical Device available for sale or lease to Wound Care Centers or any other Medical Facilities.The Arobella 1000D is designed for non-contact or debridement ultrasound wound healing therapy, or any other wounds
AneuGraft® is a stent 100% covered with a heterologous tissue, designed to set a barrier between the coronary blood vessel wall and its lumen. It is intended for situations in tortuous vessels.
The product, not approved in the U.S., is indicated for treatment of bypass stenosis, aneurysms and for emergency situations such as perforations in tortuous vessels.
